{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20260624",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "86352",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/217639Orig1s007ltr.pdf",
              "date": "20260626",
              "type": "Letter"
            },
            {
              "id": "86381",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217639s007lbl.pdf",
              "date": "20260629",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20231109",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "76565",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/217639Orig1s001ltr.pdf",
              "date": "20231114",
              "type": "Letter"
            },
            {
              "id": "76609",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217639Orig1s001correctedlbl.pdf",
              "date": "20260224",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20230127",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "73328",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/217639Orig1s000correctedltr.pdf",
              "date": "20230202",
              "type": "Letter"
            },
            {
              "id": "73639",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/217639Orig1s000TOC.html",
              "date": "20230301",
              "type": "Review"
            },
            {
              "id": "85110",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217639Orig1s001correctedlbl.pdf",
              "date": "20260224",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA217639",
      "sponsor_name": "STEMLINE THERAP",
      "openfda": {
        "application_number": [
          "NDA217639"
        ],
        "brand_name": [
          "ORSERDU"
        ],
        "generic_name": [
          "ELACESTRANT"
        ],
        "manufacturer_name": [
          "Stemline Therapeutics, Inc."
        ],
        "product_ndc": [
          "72187-0101",
          "72187-0102"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ELACESTRANT"
        ],
        "rxcui": [
          "2628478",
          "2628484",
          "2628487",
          "2628489"
        ],
        "spl_id": [
          "040abaf0-7a15-11f1-b55a-0800200c9a66"
        ],
        "spl_set_id": [
          "aa66ae5c-2bd2-4444-8178-b55651e054ef"
        ],
        "package_ndc": [
          "72187-0101-3",
          "72187-0102-3"
        ],
        "nui": [
          "N0000175582",
          "N0000000145",
          "N0000185503",
          "N0000190113"
        ],
        "pharm_class_epc": [
          "Estrogen Receptor Antagonist [EPC]"
        ],
        "pharm_class_moa": [
          "Estrogen Receptor Antagonists [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]"
        ],
        "unii": [
          "FM6A2627A8"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "ORSERDU",
          "active_ingredients": [
            {
              "name": "ELACESTRANT HYDROCHLORIDE",
              "strength": "EQ 86MG BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "ORSERDU",
          "active_ingredients": [
            {
              "name": "ELACESTRANT HYDROCHLORIDE",
              "strength": "EQ 345MG BASE"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}